Read More Pharma Industry News Tempus joins forces with Whitehawk Therapeutics to power next-gen biomarker-based oncology trials Find out how Tempus and Whitehawk are using AI and real-world data to transform biomarker-driven oncology—discover the collaboration’s science and market impact. bySoujanya RaviOctober 16, 2025